The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

被引:19
|
作者
Fu, Wing-Yu [1 ,2 ]
Ip, Nancy Y. [1 ,2 ,3 ]
机构
[1] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, State Key Lab Mol Neurosci,Clear Water Bay,Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Shenzhen Hong Kong Inst Brain Sci, HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen 518057, Guangdong, Peoples R China
关键词
Synapses; Genetic risks; Synaptic vesicles; Neurotransmitter release; Neurotransmission; Synaptic plasticity; Protein trafficking; GENOME-WIDE ASSOCIATION; APOE GENOTYPE; RECEPTOR FUNCTION; PROTEIN CD2AP; PLASTICITY; ADAM10; TREM2; BETA; PHOSPHORYLATION; MUTATIONS;
D O I
10.1016/j.semcdb.2022.07.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions. Due to the extended global life expectancy, the prevalence of AD is increasing among aging populations worldwide. While AD is a multifactorial disease, synaptic dysfunction is one of the major neuro-pathological changes that occur early in AD, before clinical symptoms appear, and is associated with the pro-gression of cognitive deterioration. However, the underlying pathological mechanisms leading to this synaptic dysfunction remains unclear. Recent large-scale genomic analyses have identified more than 40 genetic risk factors that are associated with AD. In this review, we discuss the functional roles of these genes in synapto-genesis and synaptic functions under physiological conditions, and how their functions are dysregulated in AD. This will provide insights into the contributions of these encoded proteins to synaptic dysfunction during AD pathogenesis.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [41] Combinatorial effect of genetic factors predicts microglia dysfunction in Alzheimer's Disease
    Fauro, G. Leguia
    Watzeels, T.
    Kucukali, F.
    Sleegers, K.
    Mancuso, R.
    GLIA, 2023, 71 : E332 - E332
  • [42] Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
    Reddy, PH
    Mani, G
    Park, BS
    Jacques, J
    Murdoch, G
    Whetsell, W
    Kaye, J
    Manczak, M
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (02) : 103 - 117
  • [43] The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
    Moxin Wu
    Manqing Zhang
    Xiaoping Yin
    Kai Chen
    Zhijian Hu
    Qin Zhou
    Xianming Cao
    Zhiying Chen
    Dan Liu
    Translational Neurodegeneration, 10
  • [44] The role of pathological tau in synaptic dysfunction in Alzheimer's diseases
    Wu, Moxin
    Zhang, Manqing
    Yin, Xiaoping
    Chen, Kai
    Hu, Zhijian
    Zhou, Qin
    Cao, Xianming
    Chen, Zhiying
    Liu, Dan
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [45] Genetic factors in Alzheimer's disease
    Bird, TD
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09): : 862 - 864
  • [46] Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease
    Perdigao, Catarina
    Barata, Mariana A.
    Araujo, Margarida N.
    Mirfakhar, Farzaneh S.
    Castanheira, Jorge
    Guimas Almeida, Claudia
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [47] Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer's Disease
    Agnello, Luisa
    Lo Sasso, Bruna
    Vidali, Matteo
    Scazzone, Concetta
    Piccoli, Tommaso
    Gambino, Caterina Maria
    Bivona, Giulia
    Giglio, Rosaria Vincenza
    Ciaccio, Anna Maria
    La Bella, Vincenzo
    Ciaccio, Marcello
    DIAGNOSTICS, 2021, 11 (12)
  • [48] Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
    Diane Bairamian
    Sha Sha
    Nathalie Rolhion
    Harry Sokol
    Guillaume Dorothée
    Cynthia A. Lemere
    Slavica Krantic
    Molecular Neurodegeneration, 17
  • [49] Synaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
    Ke Li
    Qing Wei
    Fang-Fang Liu
    Fan Hu
    Ao-ji Xie
    Ling-Qiang Zhu
    Dan Liu
    Molecular Neurobiology, 2018, 55 : 3021 - 3032
  • [50] Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
    Chen, Yu
    Fu, Amy K. Y.
    Ip, Nancy Y.
    PHARMACOLOGY & THERAPEUTICS, 2019, 195 : 186 - 198